Strongly Altered Receptor Binding Properties in PP and NPY Chimeras Are Accompanied by Changes in Structure and Membrane Binding^,

Abstract

Neuropeptide Y (NPY) and the pancreatic polypeptide (PP) are members of the neuropeptide Y family of hormones. They bind to the Y receptors with very different affinities: Whereas PP is highly selective for the Y(4) receptor, NPY displays highest affinites for Y(1), Y(2), and Y(5) receptor subtypes. Introducing the NPY segment 19-23 into PP leads to an increase in affinity at the Y(1) and Y(2) receptor subtypes whereas the exchange of this segment from PP into NPY leads to a large decrease in affinity at all receptor subtypes. PP displays a very stable structure in solution, with the N terminus being back-folded onto the C-terminal alpha-helix (the so-called PP-fold). The helix of NPY is less stable and the N terminus is freely diffusing in solution. The exchange of this segment, however, does not alter the PP-fold propensities of the chimeric peptides in solution. The structures of the phospholipid micelle-bound peptides serving to mimic the membrane-bound species display segregation into a more flexible N-terminal region and a well-defined alpha-helical region. The introduction of the [19-23]-pNPY segment into hPP leads to an N-terminal extension of the alpha-helix, now starting at Pro(14) instead of Met(17). In contrast, a truncated helix is observed in [(19)(-)(23)hPP]-pNPY, starting at Leu(17) instead of Ala(14). All peptides display moderate binding affinities to neutral membranes (K(assoc) in the range of 1.7 to 6.8 x 10(4) mol(-)(1) as determined by surface plasmon resonance) with the differences in binding being most probably related to the exchange of Arg-19 (pNPY) by Glu-23 (hPP). Differences in receptor binding properties between the chimeras and their parental peptides are therefore most likely due to changes in the conformation of the micelle-bound peptides.

Structure, Sulfatide Binding Properties, and Inhibition of Platelet Aggregation by a Disabled-2 Protein-derived Peptide

“…3D). Peptides bound to lipid surfaces generally display complex biphasic traces for both association and dissociation phases because they initially bind to the lipid head groups followed by insertion into the acyl chain region of the liposome (40,41). Initial association of Dab2 SBM to sulfatide liposomes occurs rapidly, and the process is followed by accumulation of the peptide on the lipid surface (Fig.…”

Surface Plasmon Resonance Assay of Binding Properties of Antisense Oligonucleotides to Serum Albumins and Lipoproteins

“…19 We have already evaluated interactions of various drugs to the target using the SPR biosensor, and demonstrated that it can be used to readily determine the kinetic rate constants and the affinity of ligand interactions. [20][21][22][23][24][25][26][27][28] This information can offer important insights into the mechanism of such interactions.…”

Binding Properties of Antimicrobial Agents to Lipid Membranes Using Surface Plasmon Resonance

“…13) We have already established the evaluation of interactions of various antimicrobial peptides to ligands using SPR biosensors, and demonstrated that the kinetic rate constants and the affinities of ligand interactions can be readily determined by this technique, which in turn provides important insights into the interaction mechanisms. [14][15][16] Also, our SPR techniques have already been used to evaluate the binding properties of an antimicrobial agent (Daptomycin) and antifungal agents (Amphotericin B and Fungizone) to lipid membranes. [17][18][19] Glycopeptide antibiotics are widely used to treat various infections caused by Gram-positive bacteria by inhibiting proper cell wall synthesis, specifically, by binding to the D-alanyl-D-alanine residues on the ends of the peptide chains of the membrane-anchoring cell wall precursor, lipid II.…”